{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T13:57:30Z","timestamp":1784901450205,"version":"3.55.0"},"reference-count":47,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Hypertensive disorders of pregnancy (HDP) are one of the leading causes of maternal morbidity and death. There is an urgent need to improve early identification of women at risk of HDP, and assessment of pregestational cardiometabolic biomarkers is a potential way forward.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To investigate pregestational cardiometabolic disturbances with regard to risk of HDP.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This prospective cohort study used data from the Apolipoprotein-Related Mortality Risk (AMORIS) cohort, a population-based study set in the greater Stockholm area of Sweden, linked to the Swedish Medical Birth Register from January 1, 1985, to December 31, 2020. Participants were nulliparous women 18 years of age or older with blood biomarker data obtained before their first completed pregnancy. Data analyses were conducted from January 1 to October 31, 2025.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Pregestational cardiometabolic disturbances, identified through biomarkers of lipid and glucose metabolism and low-grade inflammation. Median time between blood sampling and the start of pregnancy was 4 to 6 years (range, 0-31 years).<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n HDP, defined as gestational hypertension, preeclampsia, or superimposed preeclampsia.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Of 35\u202f189 women included (mean [SD] age at delivery, 30.9 [4.8] years), 1938 (5.5%) had HDP. In groups identified with pregestational cardiometabolic disturbances, the percentages with HDP were between 5.5% and 12.8%, whereas the percentages in the comparison categories were between 4.1% and 5.3%. In multivariable logistic regression models, associations with increased risk of HDP were observed for quartile (Q) 4 (vs Q1) for total cholesterol (adjusted odds ratio [AOR], 1.23 [95% CI, 1.06-1.41]), low-density lipoprotein cholesterol (AOR, 1.41 [95% CI, 1.05-1.89]), triglycerides (AOR, 1.19 [95% CI, 1.03-1.37]), haptoglobin (AOR, 1.20 [95% CI, 1.02-1.42]), apolipoprotein (Apo) B (AOR, 1.90 [95% CI, 1.36-2.65]), ApoB\/ApoA1 ratio (AOR, 1.59 [95% CI, 1.10-2.30]), and the triglyceride-glucose index (AOR, 1.21 [95% CI, 1.04-1.40]). For C-reactive protein (AOR, 0.97 [95% CI, 0.80-1.17]) and leukocyte counts (AOR, 0.98 [95% CI, 0.80-1.20]), there was no association with HDP risk.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cohort study, pregestationally assessed cardiometabolic biomarkers were associated with increased risk of HDP in nulliparous women. For some biomarkers, the increased risk was observed below standard cutoff levels for a clinical diagnosis, that is, at subclinical levels. These results suggest that assessment of cardiometabolic biomarkers may improve identification of women at risk of HDP, both in preconceptional counseling settings and at enrollment in antenatal health care.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.10037","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:30:57Z","timestamp":1777563057000},"page":"e2610037","source":"Crossref","is-referenced-by-count":2,"title":["Pregestational Cardiometabolic Biomarkers and Future Hypertensive Disorders of Pregnancy"],"prefix":"10.1001","volume":"9","author":[{"given":"Angelika","family":"Qvick","sequence":"first","affiliation":[{"name":"Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sandstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Medicine, Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Obstetrics and Gynecology, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Norhammar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden"},{"name":"Capio St G\u00f6rans Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Vikstr\u00f6m","sequence":"additional","affiliation":[{"name":"Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Clara","family":"Spetz Holm","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Clinical Sciences, Link\u00f6ping University, Link\u00f6ping, Sweden"},{"name":"Clinical Department of Obstetrics and Gynaecology in Link\u00f6ping, Region \u00d6sterg\u00f6tland, Link\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecka","family":"Hultgren","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Vascular Surgery, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Hammar","sequence":"additional","affiliation":[{"name":"Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Leander","sequence":"additional","affiliation":[{"name":"Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"issue":"4","key":"zoi260311r1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.bpobgyn.2011.01.006","article-title":"Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy.","volume":"25","author":"Hutcheon","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"3","key":"zoi260311r2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/hr.2016.126","article-title":"Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis.","volume":"40","author":"Umesawa","year":"2017","journal-title":"Hypertens Res"},{"issue":"7","key":"zoi260311r3","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1111\/jch.14254","article-title":"Prevalence of hypertensive disorders during pregnancy in France (2010-2018): the Nationwide CONCEPTION Study.","volume":"23","author":"Oli\u00e9","year":"2021","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"3","key":"zoi260311r4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2024.100864","article-title":"Hypertensive disorders of pregnancy: innovative management strategies.","volume":"3","author":"Radparvar","year":"2024","journal-title":"JACC Adv"},{"issue":"26","key":"zoi260311r5","doi-asserted-by":"publisher","first-page":"E897","DOI":"10.1503\/cmaj.231547","article-title":"Trends in rate of hypertensive disorders of pregnancy and associated morbidities in Canada: a population-based study (2012-2021).","volume":"196","author":"Dzakpasu","year":"2024","journal-title":"CMAJ"},{"issue":"6","key":"zoi260311r6","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis.","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob Health"},{"key":"zoi260311r7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-072157","article-title":"Maternal hypertensive disorder of pregnancy and mortality in offspring from birth to young adulthood: national population based cohort study.","volume":"379","author":"Huang","year":"2022","journal-title":"BMJ"},{"issue":"19","key":"zoi260311r8","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMra2109523","article-title":"Preeclampsia.","volume":"386","author":"Magee","year":"2022","journal-title":"N Engl J Med"},{"issue":"8","key":"zoi260311r9","doi-asserted-by":"publisher","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 Heart disease and stroke statistics: a report of US and global data from the American Heart Association.","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"issue":"2","key":"zoi260311r10","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023791","article-title":"Trends in the incidence of new-onset hypertensive disorders of pregnancy among rural and urban areas in the United States, 2007 to 2019.","volume":"11","author":"Cameron","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"18","key":"zoi260311r11","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1016\/j.jacc.2020.03.028","article-title":"Incidence and long-term outcomes of hypertensive disorders of pregnancy.","volume":"75","author":"Garovic","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"zoi260311r12","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1161\/HYP.0000000000000208","article-title":"Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association.","volume":"79","author":"Garovic","year":"2022","journal-title":"Hypertension"},{"issue":"1","key":"zoi260311r13","doi-asserted-by":"publisher","first-page":"R27","DOI":"10.1530\/JOE-16-0340","article-title":"Vascular adaptation in pregnancy and endothelial dysfunction in preeclampsia.","volume":"232","author":"Boeldt","year":"2017","journal-title":"J Endocrinol"},{"issue":"7","key":"zoi260311r14","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: pathophysiology, challenges, and perspectives.","volume":"124","author":"Rana","year":"2019","journal-title":"Circ Res"},{"key":"zoi260311r15","doi-asserted-by":"publisher","first-page":"i1753","DOI":"10.1136\/bmj.i1753","article-title":"Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies.","volume":"353","author":"Bartsch","year":"2016","journal-title":"BMJ"},{"issue":"3","key":"zoi260311r16","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s40883-021-00243-w","article-title":"Pre-eclampsia: a scoping review of risk factors and suggestions for future research direction.","volume":"8","author":"Lee","year":"2022","journal-title":"Regen Eng Transl Med"},{"issue":"4","key":"zoi260311r17","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/aje\/kwu145","article-title":"Maternal hyperlipidemia and the risk of preeclampsia: a meta-analysis.","volume":"180","author":"Spracklen","year":"2014","journal-title":"Am J Epidemiol"},{"issue":"12","key":"zoi260311r18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243538","article-title":"Maternal lipid profile and risk of pre-eclampsia in African pregnant women: a systematic review and meta-analysis.","volume":"15","author":"Tesfa","year":"2020","journal-title":"PLoS One"},{"issue":"10","key":"zoi260311r19","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1089\/jwh.2018.7560","article-title":"Cardiovascular disease-related pregnancy complications are associated with increased maternal levels and trajectories of cardiovascular disease biomarkers during and after pregnancy.","volume":"29","author":"Parikh","year":"2020","journal-title":"J Womens Health (Larchmt)"},{"issue":"4","key":"zoi260311r20","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3897\/folmed.63.e56489","article-title":"High-sensitivity CRP levels in women with gestational hypertension, preeclampsia and in normotensive pregnant women and its correlations.","volume":"63","author":"Gencheva","year":"2021","journal-title":"Folia Med (Plovdiv)"},{"key":"zoi260311r21","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.diabres.2018.03.038","article-title":"The association between pre-pregnancy impaired fasting glucose and adverse perinatal outcome.","volume":"140","author":"Salman","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"zoi260311r22","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.ijcard.2015.11.109","article-title":"Metabolic syndrome in the non-pregnant state is associated with the development of preeclampsia.","volume":"203","author":"Cho","year":"2016","journal-title":"Int J Cardiol"},{"issue":"9","key":"zoi260311r23","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1111\/1471-0528.17084","article-title":"The adverse cardiovascular risk factor profile of women with pre-eclampsia develops over time in the years before pregnancy.","volume":"129","author":"Retnakaran","year":"2022","journal-title":"BJOG"},{"issue":"15","key":"zoi260311r24","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.009250","article-title":"Life course trajectories of cardiovascular risk factors in women with and without hypertensive disorders in first pregnancy: the HUNT Study in Norway.","volume":"7","author":"Haug","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"zoi260311r25","doi-asserted-by":"publisher","first-page":"68e1","DOI":"10.1016\/j.ajog.2012.05.017","article-title":"Prepregnancy cardiometabolic and inflammatory risk factors and subsequent risk of hypertensive disorders of pregnancy.","volume":"207","author":"Hedderson","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"zoi260311r26","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1097\/EDE.0b013e318225c960","article-title":"Preconception cardiovascular risk factors and pregnancy outcome.","volume":"22","author":"Harville","year":"2011","journal-title":"Epidemiology"},{"issue":"10","key":"zoi260311r27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040297","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.","volume":"4","author":"Vandenbroucke","year":"2007","journal-title":"PLoS Med"},{"issue":"4","key":"zoi260311r28","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1093\/ije\/dyw333","article-title":"Cohort profile: the AMORIS cohort.","volume":"46","author":"Walldius","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"1","key":"zoi260311r29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10654-022-00947-5","article-title":"The Swedish medical birth register during five decades: documentation of the content and quality of the register.","volume":"38","author":"Cnattingius","year":"2023","journal-title":"Eur J Epidemiol"},{"key":"zoi260311r30","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register.","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"issue":"7","key":"zoi260311r31","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish Prescribed Drug Register\u2013opportunities for pharmacoepidemiological research and experience from the first six months.","volume":"16","author":"Wettermark","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"zoi260311r32","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10654-019-00511-8","article-title":"The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research.","volume":"34","author":"Ludvigsson","year":"2019","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"zoi260311r33","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.2337\/diacare.26.4.1270","article-title":"The National Diabetes Register in Sweden: an implementation of the St. Vincent Declaration for Quality Improvement in Diabetes Care.","volume":"26","author":"Gudbj\u00f6rnsdottir","year":"2003","journal-title":"Diabetes Care"},{"key":"zoi260311r34","first-page":"i","article-title":"Obesity: preventing and managing the global epidemic. Report of a WHO consultation.","volume":"894","year":"2000","journal-title":"World Health Organ Tech Rep Ser"},{"key":"zoi260311r35","first-page":"35","article-title":"High cholesterol and triglyceride values in Swedish males and females: increased risk of fatal myocardial infarction. First report from the AMORIS (Apolipoprotein related MOrtality RISk) study.","volume":"4","author":"Walldius","year":"1992","journal-title":"Blood Press Suppl"},{"issue":"10","key":"zoi260311r36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111463","article-title":"Fructosamine is a useful indicator of hyperglycaemia and glucose control in clinical and epidemiological studies\u2013cross-sectional and longitudinal experience from the AMORIS cohort.","volume":"9","author":"Malmstr\u00f6m","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"zoi260311r37","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.atherosclerosis.2010.08.049","article-title":"Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study (AMORIS).","volume":"213","author":"Holme","year":"2010","journal-title":"Atherosclerosis"},{"issue":"2","key":"zoi260311r38","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.preghy.2014.02.001","article-title":"The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP.","volume":"4","author":"Tranquilli","year":"2014","journal-title":"Pregnancy Hypertens"},{"issue":"6","key":"zoi260311r39","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research.","volume":"38","author":"Austin","year":"2009","journal-title":"Commun Stat Simul Comput"},{"issue":"9","key":"zoi260311r40","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/sim.3841","article-title":"Dose-response analyses using restricted cubic spline functions in public health research.","volume":"29","author":"Desquilbet","year":"2010","journal-title":"Stat Med"},{"issue":"7627","key":"zoi260311r41","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1136\/bmj.39366.416817.BE","article-title":"Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study.","volume":"335","author":"Magnussen","year":"2007","journal-title":"BMJ"},{"issue":"10","key":"zoi260311r42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139164","article-title":"Pre-conception dyslipidemia is associated with development of preeclampsia and gestational diabetes mellitus.","volume":"10","author":"Baumfeld","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"zoi260311r44","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1161\/CIRCULATIONAHA.110.943407","article-title":"Hypertension in pregnancy and later cardiovascular risk: common antecedents?","volume":"122","author":"Romundstad","year":"2010","journal-title":"Circulation"},{"issue":"2","key":"zoi260311r45","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S2213-8587(25)00295-5","article-title":"Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study.","volume":"14","author":"Vazquez Arreola","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"zoi260311r47","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12872-016-0257-8","article-title":"Blood pressure changes during 22-year of follow-up in large general population - the HUNT Study, Norway.","volume":"16","author":"Holmen","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"key":"zoi260311r43","unstructured":"United Kingdom: Hypertension in pregnancy: diagnosis and management. National Institute for Health and Care Excellence (NICE). 2019. Accessed March 6, 2026. https:\/\/www.nice.org.uk\/guidance\/ng133"},{"key":"zoi260311r46","unstructured":"Mean age of women at birth of first child. UNECE (United Nations Economic Commission for Europe). 2024. Accessed March 6, 2026. https:\/\/w3.unece.org\/PXWeb\/en\/Table?IndicatorCode=34"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2848401\/qvick_2026_oi_260311_1776978912.0697.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:31:01Z","timestamp":1777563061000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2848401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.10037","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]}}}